Quick Answer
TuHURA Biosciences, Inc./NV reported Stockholders Equity of $20.93 million for fiscal year 2025.
TuHURA Biosciences, Inc./NV Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $20.93M | +43.4% |
| 2024 | $14.59M | +288.4% |
| 2024 | $3.76M | +341.0% |
| 2023 | -$1.56M | -313.2% |
| 2023 | $731.0K | -94.1% |
| 2022 | $12.30M | +4.3% |
| 2022 | $11.79M | +11.5% |
| 2021 | $10.58M | +3923.2% |
| 2020 | $263.0K | -86.6% |
| 2019 | $1.97M | -63.8% |
| 2018 | $5.44M | -17.4% |
| 2017 | $6.58M | +35.4% |
| 2016 | $4.86M | +691.5% |
| 2015 | -$821.5K | -193.3% |
| 2014 | $880.5K | +207.6% |
| 2013 | -$818.0K | +89.4% |
| 2013 | -$7.71M | -480.8% |
| 2012 | -$1.33M | -51.4% |
| 2011 | -$877.1K | -57758.4% |
| 2010 | -$1.5K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $16.78M | +706.3% | -13.7% |
| June 30, 2025 | $19.45M | +379.5% | +97.3% |
| March 31, 2025 | $9.86M | +262.5% | -32.5% |
| December 31, 2024 | $14.59M | +1036.3% | +627.4% |
| September 30, 2024 | -$2.77M | -36.6% | +60.2% |
| June 30, 2024 | -$6.96M | -1052.0% | -14.7% |
| March 31, 2024 | -$6.07M | -260.2% | -289.2% |
| December 31, 2023 | -$1.56M | -123.6% | +23.1% |
- TuHURA Biosciences, Inc./NV showed an increase of +43.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2010–2025 period, TuHURA Biosciences, Inc./NV’s stockholders equity has grown by 1380860.4% (from -$1.5 thousand to $20.93 million).
- The most recent figure is from TuHURA Biosciences, Inc./NV’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: